$HBIO
HARVARD BIOSCIENCE INC

2020 Q2 Form 10-Q Financial Statement

#000117184320005789 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $23.31M $29.58M $28.20M
YoY Change -21.21% -6.15% 5.39%
Cost Of Revenue $9.452M $13.63M $12.05M
YoY Change -30.65% -15.7% -10.69%
Gross Profit $13.86M $15.96M $16.15M
YoY Change -13.16% 3.91% 21.74%
Gross Profit Margin 59.45% 53.93% 57.28%
Selling, General & Admin $9.949M $10.58M $12.11M
YoY Change -5.96% -8.54% 9.78%
% of Gross Profit 71.8% 66.31% 74.96%
Research & Development $1.897M $2.771M $2.735M
YoY Change -31.54% 0.47% 13.86%
% of Gross Profit 13.69% 17.37% 16.93%
Depreciation & Amortization $1.950M $1.870M $538.0K
YoY Change 4.28% -5.08% 8.69%
% of Gross Profit 14.07% 11.72% 3.33%
Operating Expenses $13.30M $15.73M $16.27M
YoY Change -15.43% -0.06% 11.96%
Operating Profit $556.0K $228.0K -$120.0K
YoY Change 143.86% -159.69% -90.52%
Interest Expense -$1.233M $1.376M -$1.405M
YoY Change -189.61% -7.22% -257.16%
% of Operating Profit -221.76% 603.51%
Other Income/Expense, Net -$1.424M -$1.360M -$1.674M
YoY Change 4.71% -8.42% -57.93%
Pretax Income -$868.0K -$1.132M -$1.794M
YoY Change -23.32% -39.37% -65.8%
Income Tax $700.0K -$900.0K $576.0K
% Of Pretax Income
Net Earnings -$1.581M -$247.0K -$2.370M
YoY Change 540.08% -83.13% -41.68%
Net Earnings / Revenue -6.78% -0.83% -8.4%
Basic Earnings Per Share -$0.04 -$0.01 -$0.06
Diluted Earnings Per Share -$0.04 -$0.01 -$0.06
COMMON SHARES
Basic Shares Outstanding 38.47K 37.74M 37.64M
Diluted Shares Outstanding 38.47K 37.74M 37.64M

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.600M $4.900M $5.000M
YoY Change -46.94% -12.5% -16.67%
Cash & Equivalents $2.629M $4.934M $5.030M
Short-Term Investments
Other Short-Term Assets $3.582M
YoY Change
Inventory $23.18M $25.29M $26.56M
Prepaid Expenses
Receivables $14.71M $18.39M $18.79M
Other Receivables $3.600M $3.900M $3.200M
Total Short-Term Assets $44.10M $52.50M $53.60M
YoY Change -16.0% -2.22% -3.96%
LONG-TERM ASSETS
Property, Plant & Equipment $4.222M $14.20M $14.70M
YoY Change -70.27% 158.18% 152.53%
Goodwill $56.96M $57.24M $57.38M
YoY Change -0.49% 2.83% 2.02%
Intangibles $35.50M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.743M $400.0K $1.500M
YoY Change 335.75% -69.09% 10.95%
Total Long-Term Assets $106.6M $113.7M $117.7M
YoY Change -6.26% 2.1% 2.27%
TOTAL ASSETS
Total Short-Term Assets $44.10M $52.50M $53.60M
Total Long-Term Assets $106.6M $113.7M $117.7M
Total Assets $150.7M $166.2M $171.3M
YoY Change -9.34% 0.7% 0.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.596M $6.041M $7.311M
YoY Change 9.19% -21.73% -0.65%
Accrued Expenses $7.300M $6.600M $7.700M
YoY Change 10.61% -15.06% 0.14%
Deferred Revenue $3.652M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.200M $2.400M $2.200M
YoY Change 33.33% 50.0% 57.14%
Total Short-Term Liabilities $22.66M $20.90M $24.10M
YoY Change 8.44% -5.83% 8.15%
LONG-TERM LIABILITIES
Long-Term Debt $40.92M $52.40M $54.10M
YoY Change -21.91% -12.42% -12.13%
Other Long-Term Liabilities $870.0K $10.30M $10.40M
YoY Change -91.55% 151.22% 70.49%
Total Long-Term Liabilities $41.79M $62.70M $64.50M
YoY Change -33.35% 4.8% 4.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.66M $20.90M $24.10M
Total Long-Term Liabilities $41.79M $62.70M $64.50M
Total Liabilities $74.62M $85.90M $91.00M
YoY Change -13.14% -2.43% -0.71%
SHAREHOLDERS EQUITY
Retained Earnings -$130.7M
YoY Change
Common Stock $231.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $7.746M 7.746M shares 7.746M shares
Shareholders Equity $76.07M $80.33M $80.35M
YoY Change
Total Liabilities & Shareholders Equity $150.7M $166.2M $171.3M
YoY Change -9.34% 0.7% 0.21%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$1.581M -$247.0K -$2.370M
YoY Change 540.08% -83.13% -41.68%
Depreciation, Depletion And Amortization $1.950M $1.870M $538.0K
YoY Change 4.28% -5.08% 8.69%
Cash From Operating Activities $2.370M $660.0K $2.010M
YoY Change 259.09% -48.44% 348.66%
INVESTING ACTIVITIES
Capital Expenditures -$280.0K -$280.0K $143.0K
YoY Change 0.0% 86.67% -70.99%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00 $1.020M $9.000K
YoY Change -100.0% -278.95% -100.02%
Cash From Investing Activities -$280.0K $740.0K -$152.0K
YoY Change -137.84% -202.78% -99.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$421.0K
YoY Change -292.24%
Debt Paid & Issued, Net $4.583M
YoY Change -67.37%
Cash From Financing Activities -5.300M -1.540M -5.004M
YoY Change 244.16% 190.57% -109.77%
NET CHANGE
Cash From Operating Activities 2.370M 660.0K 2.010M
Cash From Investing Activities -280.0K 740.0K -152.0K
Cash From Financing Activities -5.300M -1.540M -5.004M
Net Change In Cash -3.210M -140.0K -3.143M
YoY Change 2192.86% -566.67% 532.39%
FREE CASH FLOW
Cash From Operating Activities $2.370M $660.0K $2.010M
Capital Expenditures -$280.0K -$280.0K $143.0K
Free Cash Flow $2.650M $940.0K $1.867M
YoY Change 181.91% -34.27% -4248.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38942683
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2020Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46413908
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45933715
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38668401
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38188208
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2629000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8335000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14710000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20704000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
23181000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
22061000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3582000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2472000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
44102000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
53572000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4222000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4776000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8165000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8463000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
56958000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
57381000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35495000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
38405000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1743000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2273000 USD
CY2020Q2 us-gaap Assets
Assets
150685000 USD
CY2019Q4 us-gaap Assets
Assets
164870000 USD
CY2020Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
2807000 USD
CY2019Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
6900000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2249000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2424000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6596000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5339000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3652000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3949000 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
969000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
609000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6390000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6091000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22663000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25312000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40921000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46917000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2276000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1974000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7887000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8224000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
870000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
749000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
74617000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
83176000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
438000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
438000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
230675000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
229189000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130673000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124576000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13704000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12689000 USD
CY2020Q2 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2019Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76068000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
81694000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
150685000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
164870000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23308000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29584000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47079000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57786000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9452000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13629000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20241000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25677000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
13856000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
15955000 USD
us-gaap Gross Profit
GrossProfit
26838000 USD
us-gaap Gross Profit
GrossProfit
32109000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4279000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5770000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9858000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12076000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5670000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4809000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12429000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10612000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1897000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2771000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4387000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5506000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1454000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1436000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2881000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2866000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
941000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
941000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
13300000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
15727000 USD
us-gaap Operating Expenses
OperatingExpenses
29555000 USD
us-gaap Operating Expenses
OperatingExpenses
32001000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
556000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
228000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2717000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
108000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1233000 USD
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1376000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2532000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2781000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-191000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-253000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1424000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1360000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2612000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3034000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-868000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1132000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5329000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2926000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
713000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-885000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
768000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-309000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-247000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2617000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38468000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37736000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38389000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37683000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38468000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37736000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38389000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37683000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-247000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2617000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
619000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-195000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-957000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-191000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-11000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-298000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-227000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-494000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-97000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-19000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-169000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-36000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
86000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-279000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-58000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-458000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-474000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1015000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-649000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-876000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-721000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7112000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3266000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
76009000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
167000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
769000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1581000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
705000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76068000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
80349000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
89000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
615000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-247000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-474000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
80330000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
81694000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
167000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
262000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1562000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1015000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76068000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
82724000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
89000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
423000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1206000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2617000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-649000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
80330000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6097000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2617000 USD
us-gaap Depreciation
Depreciation
982000 USD
us-gaap Depreciation
Depreciation
972000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
941000 USD
hbio Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation
AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation
2881000 USD
hbio Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation
AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation
2866000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
197000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
189000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1562000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1206000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
368000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-419000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5855000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2681000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1374000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
209000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
601000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-150000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1250000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1382000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
343000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-361000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
332000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1371000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-276000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-288000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-233000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-487000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5244000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2667000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
524000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
423000 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1020000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
9000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-524000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
588000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
6115000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2300000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
22061000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5672000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5569000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5267000 USD
CY2020Q2 hbio Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
10205000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
16411000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8503000 USD
hbio Net Taxes Paid Net Proceeds From Issuance Of Common Stock
NetTaxesPaidNetProceedsFromIssuanceOfCommonStock
-75000 USD
hbio Net Taxes Paid Net Proceeds From Issuance Of Common Stock
NetTaxesPaidNetProceedsFromIssuanceOfCommonStock
-334000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10371000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6537000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-55000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5706000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3239000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8335000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8173000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2629000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4934000 USD
us-gaap Interest Paid Net
InterestPaidNet
2549000 USD
us-gaap Interest Paid Net
InterestPaidNet
2861000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
98000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
299000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;"> <tbody> <tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b><em style="font: inherit;">2.</em></b></td> <td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Recently Issued Accounting Pronouncements</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;"><i>Accounting Pronouncements to be Adopted</i></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">In <em style="font: inherit;"> June 2016, </em>the FASB issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">13,</em> <i>Financial Instruments—Credit Losses (Topic <em style="font: inherit;">326</em>): Measurement of Credit Losses on Financial</i> <i>Instruments, </i>which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred<i> </i>losses to estimate credit losses on certain types of financial instruments, including trade receivables. This <em style="font: inherit;"> may </em>result in the earlier recognition of allowances for losses. The FASB issued several ASUs after ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> to clarify implementation guidance and to provide transition relief for certain entities. ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> is effective for the Company for fiscal years beginning after <em style="font: inherit;"> December 15, 2022, </em>with early adoption permitted. The Company is evaluating the impact of adopting ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> and related amendments will have on its consolidated financial position, results of operations and cash flows.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">In <em style="font: inherit;"> August 2018, </em>the FASB issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2018</em>-<em style="font: inherit;">14,</em> <i>Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans</i>, which amends ASC <em style="font: inherit;">715</em> to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years beginning after <em style="font: inherit;"> December 15, 2020, </em>with early adoption permitted. Management has <em style="font: inherit;">not</em> yet completed its assessment of the impact of the new standard on the Company’s Consolidated Financial Statements.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">In <em style="font: inherit;"> December 2019, </em>the FASB issued ASU <em style="font: inherit;">2019</em>-<em style="font: inherit;">12,</em> <i>Income Taxes (Topic <em style="font: inherit;">740</em>): Simplifying the Accounting for Income Taxes</i>, which enhances and simplifies various aspects of the income tax accounting guidance related to intra-period tax allocation, interim period accounting for enacted changes in tax law, and the year-to-date loss limitation in interim period tax accounting. ASU <em style="font: inherit;">2019</em>-<em style="font: inherit;">12</em> also amends other aspects of the guidance to reduce complexity in certain areas. ASU <em style="font: inherit;">2019</em>-<em style="font: inherit;">12</em> will become effective for the Company on <em style="font: inherit;"> January 1, 2021. </em>Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its financial statements and related disclosures.</p>
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35260000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
57381000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-423000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
56958000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
67653000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32393000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35260000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
67023000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29753000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
37270000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
235000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1135000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35495000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
38405000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2844000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5703000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5749000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5561000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3929000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3153000 USD
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13503000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13347000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
23181000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2924000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2554000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
563000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
395000 USD
CY2020Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
193000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
252000 USD
CY2020Q2 hbio Customer Related Costs
CustomerRelatedCosts
996000 USD
CY2019Q4 hbio Customer Related Costs
CustomerRelatedCosts
963000 USD
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
415000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
425000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1299000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1502000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6390000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6091000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
368000 USD
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
874000 USD
CY2020Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-45000 USD
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
605000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
592000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
748000 USD
CY2020Q2 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
168000 USD
CY2020Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
557000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
615000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
600000 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
544000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
515000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1079000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1038000 USD
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
43000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
51000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
85000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
127000 USD
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
25000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
103000 USD
us-gaap Sublease Income
SubleaseIncome
132000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1923000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1244000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
463000 USD
us-gaap Lease Cost
LeaseCost
1032000 USD
us-gaap Lease Cost
LeaseCost
960000 USD
us-gaap Sublease Income
SubleaseIncome
205000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
562000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1381000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1367000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
387000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8165000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8463000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2249000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2424000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7887000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8224000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10136000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10648000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y8M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y1M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092 pure
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092 pure
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2241000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1988000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1929000 USD
CY2020Q2 hbio Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
5314000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14639000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4503000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10136000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3700000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
24608929
CY2019Q2 hbio Fungible Share Ratio For Deferred Stock Awards
FungibleShareRatioForDeferredStockAwards
1.79 pure
CY2020Q2 hbio Fungible Share Ratio For Deferred Stock Awards
FungibleShareRatioForDeferredStockAwards
1.49 pure
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3264267
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2266122
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
894154
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.61
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7359
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
15819
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
233080
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.55
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2904018
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.56
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6500000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
769000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
615000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1562000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1206000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.21
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.56
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38467686
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37735717
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38389358
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37682539
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38467686
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37735717
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38389358
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37682539
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5727716
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3300586
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
983000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1180000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
43728000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
53817000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000 USD
CY2020Q2 hbio Excess Cash Sweep
ExcessCashSweep
-0 USD
CY2019Q4 hbio Excess Cash Sweep
ExcessCashSweep
4093000 USD
CY2020Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
393000 USD
CY2019Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
393000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40921000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46917000 USD
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
-300000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23308000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29584000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47079000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57786000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3700000 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3500000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3673000 USD
CY2020Q2 hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
643000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
634000 USD
CY2020Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-30000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3652000 USD
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3715000 USD
CY2019Q2 hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
421000 USD
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
594000 USD
CY2019Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-10000 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3532000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3949000 USD
hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1174000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1455000 USD
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-16000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3652000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3820000 USD
hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1377000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1665000 USD
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
0 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3532000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
325000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
332000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
368000 USD
hbio Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries
AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries
40000 USD
hbio Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries
AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries
329000 USD
hbio Accounts Receivable Allowance For Credit Loss Effect Of Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossEffectOfForeignCurrencyTranslation
1000 USD
hbio Accounts Receivable Allowance For Credit Loss Effect Of Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossEffectOfForeignCurrencyTranslation
-1000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
290000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
370000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.821 pure
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.782 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.144 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.106 pure

Files In Submission

Name View Source Status
0001171843-20-005789-index-headers.html Edgar Link pending
0001171843-20-005789-index.html Edgar Link pending
0001171843-20-005789.txt Edgar Link pending
0001171843-20-005789-xbrl.zip Edgar Link pending
ex_196366.htm Edgar Link pending
ex_196367.htm Edgar Link pending
ex_196368.htm Edgar Link pending
ex_196369.htm Edgar Link pending
ex_196561.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hbio-20200630.xsd Edgar Link pending
hbio-20200630_cal.xml Edgar Link unprocessable
hbio-20200630_def.xml Edgar Link unprocessable
hbio-20200630_lab.xml Edgar Link unprocessable
hbio-20200630_pre.xml Edgar Link unprocessable
hboi20200630_10q.htm Edgar Link pending
hboi20200630_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending